Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-25 @ 4:07 AM
NCT ID:
NCT00237120
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed as Chronic Myelogenous Leukemia in Chronic Phase
* Previously untreated with Interferon-alpha
* Performance status is normal or capable of only limited self-care
Exclusion Criteria:
* Patients who are pregnant or possibly pregnant
* Significant hepatic diseases
* Chronic Myelogenous Leukemia in advanced phase
Other protocol-defined inclusion/exclusion criteria may apply.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
74 Years
Study:
NCT00237120
Study Brief:
Protocol Section:
NCT00237120